Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689548-26-000047
Filing Date
2026-05-07
Accepted
2026-05-07 09:06:57
Documents
63
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q prax-20260331.htm   iXBRL 10-Q 796319
2 EX-31.1 exhibit31120260331.htm EX-31.1 12847
3 EX-31.2 exhibit31220260331.htm EX-31.2 14146
4 EX-32.1 exhibit32120260331.htm EX-32.1 13094
  Complete submission text file 0001689548-26-000047.txt   5354687

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prax-20260331.xsd EX-101.SCH 40857
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prax-20260331_cal.xml EX-101.CAL 58866
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prax-20260331_def.xml EX-101.DEF 173237
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prax-20260331_lab.xml EX-101.LAB 543262
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prax-20260331_pre.xml EX-101.PRE 357508
67 EXTRACTED XBRL INSTANCE DOCUMENT prax-20260331_htm.xml XML 657409
Mailing Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110 617-300-8460
Praxis Precision Medicines, Inc. (Filer) CIK: 0001689548 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39620 | Film No.: 26951174
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)